FDA Adverse Event Malfunction Summary report: N

BD PLASTIPAK¿ SYRINGES

MDR report key: 14131560 · Received April 16, 2022

Report

Report Number
3003152976-2022-00144
Event Type
Malfunction
Date Received
April 16, 2022
Date of Event
March 31, 2022
Report Date
May 16, 2022
Manufacturer
BECTON DICKINSON, S.A.
Product Code
FMF
PMA / PMN Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

DATE OF EVENT IS UNKNOWN; AWARENESS DATE HAS BEEN USED FOR THIS FIELD. A DEVICE EVALUATION IS ANTICIPATED BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Additional Manufacturer Narrative · 0

H6: INVESTIGATION SUMMARY: NO PHOTOS OR PHYSICAL SAMPLES THAT DISPLAY THE REPORTED CONDITION WERE AVAILABLE FOR INVESTIGATION. A DEVICE HISTORY REVIEW WAS PERFORMED FOR THE REPORTED LOT 2111083, NO DEVIATIONS OR NON-CONFORMANCES WERE IDENTIFIED DURING THE MANUFACTURING PROCESS THAT COULD HAVE CONTRIBUTED TO THIS ISSUE. UNUSED SAMPLES OF LOT 2111083 WERE USED FOR ADDITIONAL EVALUATION. THE PRODUCT WAS VISUALLY INSPECTED, ALL STOPPERS WERE PROPERLY ASSEMBLED, HOWEVER, DAMAGE WAS OBSERVED IN THE BARREL ON SOME OF THE PRODUCT, WHICH COULD HAVE LEAD TO THE LEAK REPORTED. FINAL PRODUCTS IN THIS MANUFACTURING LINE, FOR THIS REFERENCE ARE SAMPLED AND THEY ARE SUBJECTED TO VISUAL AND FUNCTIONAL INSPECTIONS DURING THE DIFFERENT MANUFACTURING SUB-PROCESSES ACCORDING TO PROCEDURES. WHILE WE COULD NOT IDENTIFY A DIRECT ISSUE, THE DAMAGE LIKELY OCCURRED DURING THE ASSEMBLY PROCESS.

Description of Event or Problem · 0

IT WAS REPORTED WHILE USING BD PLASTIPAK¿ SYRINGES LEAKAGE OCCURRED. THERE WAS NO REPORT OF PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: LOSS OF SOLUTION USED FOR ANTINEOPLASTIC CHEMOTHERAPY PREPARATION FROM THE SYRINGE BARREL, EXTERNAL PART OF THE PLUNGER.

Description of Event or Problem · 0

IT WAS REPORTED WHILE USING BD PLASTIPAK¿ SYRINGES LEAKAGE OCCURRED. THERE WAS NO REPORT OF PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: LOSS OF SOLUTION USED FOR ANTINEOPLASTIC CHEMOTHERAPY PREPARATION FROM THE SYRINGE BARREL, EXTERNAL PART OF THE PLUNGER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1907094 BD PLASTIPAK¿ SYRINGES PISTON SYRINGE FMF BECTON DICKINSON, S.A. 2111083

Patients

Seq Age Sex Outcome Treatment
1 Unknown